Thrombin Inhibitors in Primary PCI: The Case for Bivalirudin presented by Roxana Mehran, MD, FACC, FSCAI at CRT 2016
Supported by educational grants from The Medicines Company, AstraZeneca, Medicure, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
Session Name: Optimization of Anticoagulation for STEMI Therapy
Track: CRT 2016 Endovascular
Update in advances in endovascular procedures